---
title: "\"Performance\" Tigermed's annual net profit rises 119.2% to RMB 888 million, with a final dividend of RMB 0.126"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280986234.md"
description: "Tigermed announced its full-year results for the year ending December last year, with a revenue of RMB 6.833 billion, an increase of 3.5% year-on-year. The net profit was RMB 888 million, an increase of 119.2% year-on-year; earnings per share were RMB 1.04. A final dividend of RMB 0.126 was declared"
datetime: "2026-03-30T08:40:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280986234.md)
  - [en](https://longbridge.com/en/news/280986234.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280986234.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/280986234.md) | [繁體中文](https://longbridge.com/zh-HK/news/280986234.md)


# "Performance" Tigermed's annual net profit rises 119.2% to RMB 888 million, with a final dividend of RMB 0.126

Tigermed (03347.HK) announced its full-year results for the year ended December last year, with revenue of RMB 6.833 billion, an increase of 3.5% year-on-year. Net profit was RMB 888 million, an increase of 119.2% year-on-year; earnings per share were RMB 1.04. A final dividend of RMB 0.126 was declared

### Related Stocks

- [Tigermed (300347.CN)](https://longbridge.com/en/quote/300347.CN.md)
- [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/en/quote/516820.CN.md)
- [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/en/quote/159849.CN.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [TIGERMED (03347.HK)](https://longbridge.com/en/quote/03347.HK.md)
- [China Universal NASDAQ Biotechnology Technology ETF(QDII) (513290.CN)](https://longbridge.com/en/quote/513290.CN.md)
- [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/en/quote/516500.CN.md)
- [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/en/quote/516930.CN.md)
- [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/en/quote/159837.CN.md)

## Related News & Research

- [Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines](https://longbridge.com/en/news/280923090.md)
- [Assessing BioArctic (OM:BIOA B) Valuation After New Lecanemab Data And Regulatory Milestones](https://longbridge.com/en/news/281644038.md)
- [Sunho Biologics Flags Audit Delays as Auditor Seeks More Documentation](https://longbridge.com/en/news/280992698.md)
- [RemeGen Receives Chinese Regulatory Nod for RC288 Clinical Trial](https://longbridge.com/en/news/281458440.md)
- [22:54 ETHugel to enter ECM-based injectable market with aesthetic portfolio expansion](https://longbridge.com/en/news/281291767.md)